Short Interest in Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) Increases By 176.3%

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) saw a significant growth in short interest in February. As of February 15th, there was short interest totalling 25,700 shares, a growth of 176.3% from the January 31st total of 9,300 shares. Approximately 1.1% of the company’s shares are short sold. Based on an average trading volume of 87,100 shares, the days-to-cover ratio is presently 0.3 days.

Shuttle Pharmaceuticals Price Performance

Shares of Shuttle Pharmaceuticals stock traded down $0.00 during trading hours on Friday, hitting $0.61. The company’s stock had a trading volume of 69,677 shares, compared to its average volume of 69,576. The company has a market capitalization of $2.48 million, a PE ratio of -0.15 and a beta of -1.75. Shuttle Pharmaceuticals has a 12 month low of $0.57 and a 12 month high of $4.71. The stock has a 50 day moving average of $0.77 and a 200 day moving average of $1.13.

Shuttle Pharmaceuticals Company Profile

Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .